Loading DOC detail
Loading ticker data...
Loading DOC detail
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Chart data unavailable
Douglas Lane and Associates LLC trimmed its position in Healthpeak Properties, Inc. (NYSE: DOC) by 16.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,801,853 shares of the real estate investment trust's stock after selling 548,687 shares during the period.
Healthcare real estate investment trusts (REITs), which own properties such as senior housing, medical office buildings, skilled nursing facilities, and hospitals, may present a compelling opportunity right now. The demographic tailwind is hard to ignore: the U.S. baby boomer generation is aging rapidly, driving sustained demand for senior living and medical facilities that is not... Our Favorite Passive Income Idea Pays Big Dividends and Grows Daily
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report first quarter 2026 financial results after the close of trading on the New York Stock Exchange on Tuesday, May 5, 2026. Healthpeak will host a conference call and webcast on Wednesday, May 6, 2026 at 10:00 a.m. Eastern Time to review its financial performance and operating results. The conference call can be acces.
High-yield 'mousetrap' REITs consistently underperform, with significant risk of dividend cuts and capital loss, as evidenced by recent 12-month returns lagging VNQ by over 1,000 bps. Dividend Safety scores are critical; REITs rated F face a 40% chance of a cut within 12 months, often resulting in sharp share price declines. Key danger signals include high payout ratios, weak revenues, and heavy debt loads.
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on April 6, 2026, its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2026, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The monthly divid.
Aberdeen Group plc increased its holdings in Healthpeak Properties, Inc. (NYSE: DOC) by 4.2% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 1,356,606 shares of the real estate investment trust's stock after buying an additional 54,914 shares during the period. Aberdeen Group plc owned
Healthpeak Properties pays a monthly dividend yielding over 7%. Annaly Capital's dividend yield is more than 10 times higher than the S&P 500.
$500 per month may seem small, but it's not a trivial amount and can snowball your portfolio quickly.
Wealth Enhancement Advisory Services LLC decreased its stake in Healthpeak Properties, Inc. (NYSE: DOC) by 37.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 322,312 shares of the real estate investment trust's stock after selling 192,212 shares during the period. Wealth
U.S. equity markets fell for a fifth-straight week— pulling several major benchmarks into correction territory— as the Iran conflict remained locked in a volatile stalemate, keeping energy markets on edge. The fourth week of the Iran conflict delivered little progress toward de-escalation, as Washington maintained strikes on Iranian nuclear sites while Tehran continued retaliatory attacks across the Persian Gulf. The S&P 500 declined 2.1% this week and now sits 8.7% below its late-January record. The Dow and Nasdaq both entered "correction" territory, while the VIX volatility index topped 30.
DAVENPORT and Co LLC trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE: DOC) by 9.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 623,306 shares of the real estate investment trust's stock after selling 65,535 shares during the period. DAVENPORT and
REITs were rolling out of the gates in early-2026, coming back into favor amid a HALO trade (Heavy Assets, Low Obsolescence) after a half-decade of rate headwinds and unfavorable narrative. The oil price surge tied to the Iran conflict has complicated the rotation by sending rates soaring, yet REITs have remained surprisingly resilient in recent weeks, maintaining sizable year-to-date outperformance. REIT-rate correlations have eased in recent quarters, signaling a more favorable "regime change" where performance is driven by property fundamentals rather than macro forces, following a prolonged period of rate-dominated.
Press release – No. 6 / 2026 Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation New research hub in Cambridge, Massachusetts, in the greater Boston area, expands global discovery capabilities, combining Zealand Pharma's more than 25 years of expertise in peptides and metabolic health with Boston's biotech innovation ecosystem.
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that it has closed on a new $400 million unsecured delayed-draw term loan facility (“Term Loan”). “This new term loan enhances our liquidity and financial flexibility and further strengthens our balance sheet,” said Kelvin Moses, Chief Financial Officer of Healthpeak. “We appreciate the continued support o.
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (NYSE: JAN) (“Janus Living”) announced today that Janus Living has completed its initial public offering of 48,300,000 shares of its Class A-1 common stock, which includes the exercise in full by the underwriters of their option to purchase up to an additional 6,300,000 shares of Class A-1 common stock, at a price to the public of $20.00 per share. Shares of Janus Living's Class A-1 common sto.
